Case study · 24

Idenix Pharmaceuticals

IDENIX is a biopharmaceutical company focused on the treatment of hepatitis C virus (HCV) infections.

Brand identity

A few short months following the launch of the new brand, Merck & Co. acquired IDENIX for $3.85 billion.

Next case study